Response to letter: Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients
Ilkay Ergenc1
1Department of Gastroenterology, School of Medicine, Marmara University, İstanbul, Turkiye
2Clinic of Gastroenterology, Recep Tayyip Erdoğan University Rize Research and Training Hospital, Rize, Turkiye
3Department of Gastroenterology, School of Medicine, Marmara University, İstanbul, Turkiye; Institute of Gastroenterology, Marmara University, Istanbul, Turkiye; Department of Gastroenterology, Faculty of Medicine, Recep Tayyip Erdoğan University, Rize, Turkiye
2Clinic of Gastroenterology, Recep Tayyip Erdoğan University Rize Research and Training Hospital, Rize, Turkiye
3Department of Gastroenterology, School of Medicine, Marmara University, İstanbul, Turkiye; Institute of Gastroenterology, Marmara University, Istanbul, Turkiye; Department of Gastroenterology, Faculty of Medicine, Recep Tayyip Erdoğan University, Rize, Turkiye
Hepatology Forum - DOI: 10.14744/hf.2024.2024.0007
